Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_B1,4 | Lung | Primary cancer | 2,870 | Tumor/Malignant | 74.4% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__88_B1,5 | Lung | Primary cancer | 3,425 | Tumor/Malignant | 46.5% | 0.74 | 0.53 |
| NSCLC_38242124__IMC__88_B1,6 | Lung | Primary cancer | 3,172 | Tumor/Malignant | 62.9% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_B1,7 | Lung | Primary cancer | 3,614 | Tumor/Malignant | 79.8% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__88_B1,8 | Lung | Primary cancer | 3,530 | Tumor/Malignant | 37.3% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__88_B1,9 | Lung | Primary cancer | 3,597 | Immune | 33.8% | 0.43 | 0.90 |
| NSCLC_38242124__IMC__88_B2,10 | Lung | Primary cancer | 2,913 | Tumor/Malignant | 52.9% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_B2,11 | Lung | Primary cancer | 2,095 | Tumor/Malignant | 29.1% | 0.59 | 0.86 |
| NSCLC_38242124__IMC__88_B2,12 | Lung | Primary cancer | 3,199 | Tumor/Malignant | 58.4% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__88_B2,13 | Lung | Primary cancer | 2,837 | Tumor/Malignant | 76.4% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_B2,14 | Lung | Primary cancer | 3,699 | Tumor/Malignant | 42.8% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__88_B2,15 | Lung | Primary cancer | 2,967 | Tumor/Malignant | 53.5% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__88_B2,16 | Lung | Primary cancer | 2,965 | Stromal | 42.5% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__88_B2,2 | Lung | Primary cancer | 3,574 | Tumor/Malignant | 55.7% | 0.89 | 0.29 |
| NSCLC_38242124__IMC__88_B2,3 | Lung | Primary cancer | 5,348 | Tumor/Malignant | 62.2% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__88_B2,4 | Lung | Primary cancer | 3,042 | Tumor/Malignant | 51.6% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_B2,5 | Lung | Primary cancer | 4,928 | Tumor/Malignant | 32.2% | 0.89 | 0.36 |
| NSCLC_38242124__IMC__88_B2,6 | Lung | Primary cancer | 3,667 | Tumor/Malignant | 71.1% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__88_B2,7 | Lung | Primary cancer | 3,297 | Tumor/Malignant | 41.4% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__88_B2,9 | Lung | Primary cancer | 2,533 | Immune | 26.9% | 0.60 | 0.76 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_B1,4 | Lung | Primary cancer | 2,870 | Tumor/Malignant | 71.6% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_B1,5 | Lung | Primary cancer | 3,425 | Tumor/Malignant | 42.9% | 0.50 | 0.71 |
| NSCLC_38242124__IMC__88_B1,6 | Lung | Primary cancer | 3,172 | Tumor/Malignant | 59.1% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_B1,7 | Lung | Primary cancer | 3,614 | Tumor/Malignant | 69.8% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_B1,8 | Lung | Primary cancer | 3,530 | Tumor/Malignant | 26.0% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__88_B1,9 | Lung | Primary cancer | 3,597 | Stromal | 23.0% | 0.78 | 0.54 |
| NSCLC_38242124__IMC__88_B2,10 | Lung | Primary cancer | 2,913 | Tumor/Malignant | 52.9% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_B2,11 | Lung | Primary cancer | 2,095 | Tumor/Malignant | 27.1% | 0.34 | 1.07 |
| NSCLC_38242124__IMC__88_B2,12 | Lung | Primary cancer | 3,199 | Tumor/Malignant | 49.5% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__88_B2,13 | Lung | Primary cancer | 2,837 | Tumor/Malignant | 53.6% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__88_B2,14 | Lung | Primary cancer | 3,699 | Tumor/Malignant | 32.2% | 0.99 | 0.09 |
| NSCLC_38242124__IMC__88_B2,15 | Lung | Primary cancer | 2,967 | Tumor/Malignant | 50.6% | 0.94 | 0.16 |
| NSCLC_38242124__IMC__88_B2,16 | Lung | Primary cancer | 2,965 | Stromal | 35.9% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__88_B2,2 | Lung | Primary cancer | 3,574 | Tumor/Malignant | 37.4% | 0.75 | 0.54 |
| NSCLC_38242124__IMC__88_B2,3 | Lung | Primary cancer | 5,348 | Tumor/Malignant | 57.8% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__88_B2,4 | Lung | Primary cancer | 3,042 | Tumor/Malignant | 51.6% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_B2,5 | Lung | Primary cancer | 4,928 | Tumor/Malignant | 23.1% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__88_B2,6 | Lung | Primary cancer | 3,667 | Tumor/Malignant | 52.0% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_B2,7 | Lung | Primary cancer | 3,297 | Tumor/Malignant | 42.1% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__88_B2,9 | Lung | Primary cancer | 2,533 | Other | 25.0% | 0.37 | 1.06 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_B1,4 | Lung | Primary cancer | 2,870 | Tumor/Malignant cell | 74.0% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__88_B1,5 | Lung | Primary cancer | 3,425 | Tumor/Malignant cell | 48.1% | 0.73 | 0.55 |
| NSCLC_38242124__IMC__88_B1,6 | Lung | Primary cancer | 3,172 | Tumor/Malignant cell | 75.1% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__88_B1,7 | Lung | Primary cancer | 3,614 | Tumor/Malignant cell | 73.0% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_B1,8 | Lung | Primary cancer | 3,530 | Tumor/Malignant cell | 37.1% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__88_B1,9 | Lung | Primary cancer | 3,597 | T cell | 24.9% | 0.37 | 1.08 |
| NSCLC_38242124__IMC__88_B2,10 | Lung | Primary cancer | 2,913 | Tumor/Malignant cell | 65.6% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_B2,11 | Lung | Primary cancer | 2,095 | Tumor/Malignant cell | 23.0% | 0.64 | 0.90 |
| NSCLC_38242124__IMC__88_B2,12 | Lung | Primary cancer | 3,199 | Tumor/Malignant cell | 58.5% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__88_B2,13 | Lung | Primary cancer | 2,837 | Tumor/Malignant cell | 76.5% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_B2,14 | Lung | Primary cancer | 3,699 | Tumor/Malignant cell | 44.2% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__88_B2,15 | Lung | Primary cancer | 2,967 | Tumor/Malignant cell | 54.0% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__88_B2,16 | Lung | Primary cancer | 2,965 | Fibroblast | 41.9% | 0.90 | 0.25 |
| NSCLC_38242124__IMC__88_B2,2 | Lung | Primary cancer | 3,574 | Tumor/Malignant cell | 55.5% | 0.89 | 0.29 |
| NSCLC_38242124__IMC__88_B2,3 | Lung | Primary cancer | 5,348 | Tumor/Malignant cell | 62.2% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__88_B2,4 | Lung | Primary cancer | 3,042 | Tumor/Malignant cell | 52.7% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__88_B2,5 | Lung | Primary cancer | 4,928 | Tumor/Malignant cell | 31.1% | 0.90 | 0.35 |
| NSCLC_38242124__IMC__88_B2,6 | Lung | Primary cancer | 3,667 | Tumor/Malignant cell | 71.0% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__88_B2,7 | Lung | Primary cancer | 3,297 | Tumor/Malignant cell | 41.6% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__88_B2,9 | Lung | Primary cancer | 2,533 | Other | 25.1% | 0.74 | 0.60 |